Drug Shortage Report for TEVA-VALSARTAN/HCTZ

Last updated on 2020-01-24 History
Report ID 104333
Drug Identification Number 02357003
Brand name TEVA-VALSARTAN/HCTZ
Common or Proper name TEVA-VALSARTAN/HCTZ 160/12.5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 12.5MG 160MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-22
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-01-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare

Showing 1 to 2 of 2